James C. Lang

38.3k total citations
27 papers, 1.2k citations indexed

About

James C. Lang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, James C. Lang has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in James C. Lang's work include Cancer-related gene regulation (7 papers), Peptidase Inhibition and Analysis (5 papers) and Epigenetics and DNA Methylation (4 papers). James C. Lang is often cited by papers focused on Cancer-related gene regulation (7 papers), Peptidase Inhibition and Analysis (5 papers) and Epigenetics and DNA Methylation (4 papers). James C. Lang collaborates with scholars based in United States and Germany. James C. Lang's co-authors include Theodoros N. Teknos, David E. Schuller, Bhavna Kumar, Arti Yadav, Jeffrey J. Chalmers, Pawan Kumar, Maciej Zborowski, Liying Yang, Kris R. Jatana and Priya Balasubramanian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

James C. Lang

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James C. Lang United States	17	720	455	413	184	126	27	1.2k
Else Driehuis Netherlands	10	502 0.7×	725 1.6×	298 0.7×	443 2.4×	273 2.2×	20	1.3k
Nilva K. Cervigne Brazil	16	730 1.0×	211 0.5×	560 1.4×	36 0.2×	117 0.9×	26	1.1k
Jiong Li United States	16	815 1.1×	313 0.7×	250 0.6×	50 0.3×	122 1.0×	32	1.1k
Risto Pirinen Finland	18	686 1.0×	345 0.8×	228 0.6×	32 0.2×	156 1.2×	31	1.1k
Carmen Visús United States	16	740 1.0×	588 1.3×	403 1.0×	104 0.6×	72 0.6×	24	1.3k
Nina Raulf United Kingdom	9	482 0.7×	200 0.4×	250 0.6×	34 0.2×	75 0.6×	13	696
Bi-Jun Huang China	20	900 1.3×	283 0.6×	597 1.4×	34 0.2×	99 0.8×	29	1.2k
Kati Räsänen Finland	12	321 0.4×	410 0.9×	197 0.5×	77 0.4×	91 0.7×	18	754
Camilla L. Christensen Denmark	19	795 1.1×	600 1.3×	184 0.4×	104 0.6×	202 1.6×	34	1.4k
Wen-Lin Huang China	18	903 1.3×	351 0.8×	367 0.9×	35 0.2×	61 0.5×	26	1.3k

Countries citing papers authored by James C. Lang

Since Specialization

Citations

This map shows the geographic impact of James C. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James C. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James C. Lang more than expected).

Fields of papers citing papers by James C. Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James C. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James C. Lang. The network helps show where James C. Lang may publish in the future.

Co-authorship network of co-authors of James C. Lang

This figure shows the co-authorship network connecting the top 25 collaborators of James C. Lang. A scholar is included among the top collaborators of James C. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James C. Lang. James C. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mallery, Susan R., Daren Wang, Ping Pei, et al.. (2019). Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention. Molecular Cancer Therapeutics. 18(12). 2308–2320. 13 indexed citations

Yadav, Aarti, Bhavna Kumar, James C. Lang, Theodoros N. Teknos, & Pawan Kumar. (2017). A muscle-specific protein ‘myoferlin’ modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus. Oncogene. 36(46). 6374–6382. 16 indexed citations

Mallery, Susan R., Daren Wang, Ping Pei, et al.. (2016). Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype. Cancer Prevention Research. 10(1). 76–88. 13 indexed citations

Zhang, Manchao, Longzhu Piao, Jharna Datta, et al.. (2015). miR-124 Regulates the Epithelial-Restricted with Serine Box/Epidermal Growth Factor Receptor Signaling Axis in Head and Neck Squamous Cell Carcinoma. Molecular Cancer Therapeutics. 14(10). 2313–2320. 10 indexed citations

Islam, Mozaffarul, Jharna Datta, James C. Lang, & Theodoros N. Teknos. (2014). Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma. Oral Oncology. 50(5). 448–456. 41 indexed citations

Zhang, Manchao, Christopher E. Taylor, Longzhu Piao, et al.. (2013). Genetic and Chemical Targeting of Epithelial-Restricted with Serine Box Reduces EGF Receptor and Potentiates the Efficacy of Afatinib. Molecular Cancer Therapeutics. 12(8). 1515–1525. 5 indexed citations

Kumar, Bhavna, Arti Yadav, James C. Lang, et al.. (2012). YM155 Reverses Cisplatin Resistance in Head and Neck Cancer by Decreasing Cytoplasmic Survivin Levels. Molecular Cancer Therapeutics. 11(9). 1988–1998. 65 indexed citations

Kumar, Bhavna, Arti Yadav, James C. Lang, Theodoros N. Teknos, & Pawan Kumar. (2012). Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis. PLoS ONE. 7(5). e37601–e37601. 118 indexed citations

Kraut, Eric H., Yilong Zhang, Hao Cheng, et al.. (2010). Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN). Cancer Chemotherapy and Pharmacology. 67(3). 579–586. 16 indexed citations

10.

Richards, Kristy L., Baili Zhang, Keith Baggerly, et al.. (2009). Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability. PLoS ONE. 4(3). e4941–e4941. 103 indexed citations

11.

Colella, Stefano, Kristy L. Richards, Linda L. Bachinski, et al.. (2008). Molecular signatures of metastasis in head and neck cancer. Head & Neck. 30(10). 1273–1283. 24 indexed citations

12.

Yang, Liying, James C. Lang, Priya Balasubramanian, et al.. (2008). Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnology and Bioengineering. 102(2). 521–534. 165 indexed citations

13.

Bennett, Kristi L., Björn Hackanson, Laura T. Smith, et al.. (2007). Tumor Suppressor Activity of CCAAT/Enhancer Binding Protein α Is Epigenetically Down-regulated in Head and Neck Squamous Cell Carcinoma. Cancer Research. 67(10). 4657–4664. 74 indexed citations

14.

Smith, Laura T., Romulo Martin Brena, James C. Lang, et al.. (2006). Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. Proceedings of the National Academy of Sciences. 103(4). 982–987. 123 indexed citations

15.

Sedghizadeh, Parish P., Susan R. Mallery, Sarah Thompson, et al.. (2005). Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression. Head & Neck. 28(5). 432–440. 22 indexed citations

16.

Smith, L.T., Dominic J. Smiraglia, James C. Lang, et al.. (2005). DNA copy number gains in head and neck squamous cell carcinoma. Oncogene. 25(9). 1424–1433. 50 indexed citations

17.

Sedghizadeh, Parish P., Carl M. Allen, Karen E. Anderson, et al.. (2004). Oral graft-versus-host disease and programmed cell death: Pathogenetic and clinical correlates. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 97(4). 491–498. 7 indexed citations

18.

Dungan, Kathleen, et al.. (2002). Expression and biological effect of urodele fibroblast growth factor 1: Relationship to limb regeneration. Journal of Experimental Zoology. 292(6). 540–554. 32 indexed citations

19.

Lang, James C. & Dorit Elisabeth Schuller. (2001). Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck. British Journal of Cancer. 84(2). 237–243. 42 indexed citations

20.

Knobloch, Thomas J., Huijuan Song, Valerie DeGroff, et al.. (2001). Analysis of TGF-β type I receptor for mutations and polymorphisms in head and neck cancers. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 479(1-2). 131–139. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact